Anaptysbio Inc (ANAB) Live Share Price, Invest From India

Anaptysbio Inc Stock Performance

as on October 22, 2025 at 1:29 am IST

Day's Low
Day's High
$34
Day's Price Range
$35.39
$34.09
0.26%
Downside
3.81%
Upside
52 Week's Low
52 Week's High
$12.21
52-Week Price Range
$36.54
$34.09
64.18%
Downside
7.19%
Upside

Anaptysbio Inc share price movements today

Previous Close: $35.28
Open: $35.38
Volume: 338.7K
Day's Low - High: $34 - $35.39
52 Week Low - High: $12.21 - $36.54

Anaptysbio Inc Historical Returns

1 Month Return: + 59.39 %
3 Month Return: + 30.14 %
1 Year Return: -2.96 %
3 Year Return: + 23.5 %
5 Year Return: + 31.6 %

Anaptysbio Inc Stock Fundamentals & Key Indicators

Check Anaptysbio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$986.9M

EPS (TTM)

-4.6013

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-5.91

Industry PE ratio

-0.8798722044728434

PEG Ratio

EBITDA

-85.6M

Revenue (TTM)

123.2M

Profit Margin

-107.66%

Return On Equity TTM

21687800.00%

Anaptysbio Inc Stock Valuation

Track how Anaptysbio Inc P/E has moved over time to understand its valuation trends.

Anaptysbio Inc in the last 5 years

Overview
Trends

Lowest (-68.49x)

June 30, 2021

Today (-5.91x)

October 22, 2025

Industry (-0.88x)

October 22, 2025

Highest (90.65x)

September 30, 2021

LowHigh

Today’s Price to Earnings Ratio: -5.91x

Anaptysbio Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Anaptysbio Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Anaptysbio Inc	BUY	$986.9M	31.6%	-5.91	-107.66%
Insmed Incorporated	BUY	$34.9B	342.12%	-16.34	-259.82%
Alnylam Pharmaceuticals, Inc.	BUY	$64.4B	252.94%	-505.15	-12.96%
Vertex Pharmaceuticals Incorporated	BUY	$107.5B	102.91%	29.68	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$61.3B	0.63%	14.58	31.37%

Stock Returns calculator for Anaptysbio Inc Stock including INR - Dollar returns

The Anaptysbio Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Anaptysbio Inc investment value today

Current value as on today

₹1,01,542

Returns

₹1,542

(+1.54%)

Returns from Anaptysbio Inc Stock

₹3,016 (-3.02%)

Dollar Returns*

₹4,557 (+4.56%)

Analyst Recommendation on Anaptysbio Inc Stock

Based on 16 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 16 analysts, 75% of analysts recommend a 'BUY' rating for Anaptysbio Inc. Average target price of $62.09

Anaptysbio Inc Share Price Target

Get share price movements and forecasts by analysts on Anaptysbio Inc.

What analysts predicted

45.1%UPSIDE

Target Price

$62.09

Current Price

$34.09

Analyzed by

16 Analysts

Target

$62.09

Anaptysbio Inc target price $62.09, a slight upside of 45.1% compared to current price of $34.09. According to 16 analysts rating.

Anaptysbio Inc Stock’s Investor Sentiment and Interest

Search interest for Anaptysbio Inc Stock has increased by 1300% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 22, 2025 to October 22, 2025

Change:1300% versus previous 30 day period

Anaptysbio Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	1	3	3	9	7	10	30	43	27	22
Gross Profit	0	2	2	8	6	10	29	43	27	21
Operating Income	-44	-40	-37	-42	-42	-40	-22	-9	-27	-26
EBITDA	-39	-34	-32	-36	-37	-35	-16	-3	-27	-18
Interest Expense	4	4	4	4	6	10	15	17	18	19
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-44	-39	-37	-42	-43	-46	-32	-21	-39	-38
Income Tax Expense	4	4	4	4	0	0	0	0	0	0
Net Income	-48	-39	-37	-42	-43	-46	-32	-21	-39	-38
Net Profit Margin	-3525.84%	-1151.59%	-1124.41%	-468.75%	-612.01%	-425.30%	-109.44%	-50.53%	-141.62%	-173.52%

Anaptysbio Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	17	16	10	5	8	75	63	10	17	91
Gross Profit	0	1	-19	-51	-91	-5	-35	7	14	91
Operating Income	-3	-3	-28	-66	-107	-23	-56	-115	-164	-114
EBITDA	-4	-3	-28	-59	-95	-19	-55	-105	-143	-92
Interest Expense	0	0	1	1	1	3	1	21	18	50
Depreciation	-	-	0	0	0	0	2	2	2	2
Income Before Tax	-5	-4	-30	-61	-97	-19	-57	-128	-163	-145
Income Tax Expense	0	0	1	0	0	0	0	0	0	0
Net Income	-5	-4	-30	-61	-97	-19	-57	-128	-163	-145
Net Profit Margin	-30.76%	-25.53%	-300.70%	-1233.12%	-1216.70%	-26.56%	-90.53%	-1251.33%	-953.66%	-159.10%

Anaptysbio Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-39	-37	-42	-43	-46	-32	-21	-39	-38
Operating Cash Flow	-25	-36	-34	-44	-14	-10	-66	-10	-40
Investing Cash Flow	-20	30	49	68	-2	58	-29	14	36
Financing Cash Flow	-13	-3	-5	-6	34	71	27	-28	-50
Change in Cash	-59	-8	9	17	18	119	-68	-24	-54

Anaptysbio Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-4	-30	-61	-97	-19	-57	-128	-163	-145
Operating Cash Flow	-9	-19	-48	-69	-14	-45	-73	-120	-135
Investing Cash Flow	0	-243	-142	131	94	38	-394	144	95
Financing Cash Flow	8	292	223	-4	0	252	44	-59	127
Change in Cash	0	29	32	57	79	245	-424	-35	87

Global Institutional Holdings in Anaptysbio Inc

Funds	Holdings
EcoR1 Capital, LLC	28.17%
First Light Asset Management, LLC	12.65%
Point72 Asset Management, L.P.	8.85%
Morgan Stanley - Brokerage Accounts	6.68%
BlackRock Inc	6.39%

See all

Anaptysbio Inc News & Key Events

Insights on Anaptysbio Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, ANAB stock has moved up by 59.4%
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -39.32M → -38.63M (in $), with an average increase of 1.8% per quarter
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 59.9% return, outperforming this stock by 62.9%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 138.3% return, outperforming this stock by 114.8%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 43.11M → 22.26M (in $), with an average decrease of 27.7% per quarter

About Anaptysbio Inc

founded in 2005, anaptysbio, inc. is a privately-held company focused on the generation of antibody therapeutics, and the leader in the use of somatic hypermutation (shm) for antibody discovery and optimization. anaptysbio is building a pipeline of novel therapeutic antibody product candidates, including differentiated programs in cancer immunotherapy, inflammation, muscle wasting disorders, fibrosis and antibody-drug conjugate applications. anaptysbio’s proprietary shm-xel platform, which couples fully human antibody libraries with in vitro somatic hypermutation (shm) in mammalian cells to generate high affinity lead candidates, replicates key features of the human immune system and overcomes limitations of prior antibody technologies. by harnessing the natural mechanism of antibody maturation under controlled conditions, shm-xel allows for the selection of optimal antibody properties such as high affinity, function, cross-reactivity, epitope diversity and manufacturability. the c

Organisation	Anaptysbio Inc
Headquarters	10770 Wateridge Circle, San Diego, CA, United States, 92121-5801
Industry	Health Technology
CEO	Mr. Daniel R. Faga
E-voting on shares	Click here to vote

Key Management of Anaptysbio Inc

Name	Title
Ms. Priya Raina	Senior Vice President of Clinical Operations
Mr. Daniel R. Faga	President, CEO & Director
Mr. Eric J. Loumeau	Chief Legal Officer
Ms. Beth Mueller	Senior Vice President of Human Resources
Dr. Martin Dahl Ph.D.	Senior Vice President of Research
Mr. Benjamin Stone	Chief Business Officer
Mr. Douglas A. Rich M.B.A.	Senior Vice President of CMC
Mr. Dennis M. Mulroy	Chief Financial Officer
Dr. Paul F. Lizzul FAAD, M.B.A., M.D., M.P.H., Ph.D.	Chief Medical Officer
Ms. Monique Da Silva	Senior Vice President of Corporate Affairs

FAQs

What is Anaptysbio Inc share price today?

Anaptysbio Inc share price today is $34.09 as on October 22, 2025 at 1:29 am IST at the close of the market. Anaptysbio Inc share today touched a day high of $35.39 and a low of $34.

What is the 52 week high and 52 week low for Anaptysbio Inc share?

Anaptysbio Inc share touched a 52 week high of $36.54 on October 22, 2024 and a 52 week low of $12.21 on February 11, 2025. Anaptysbio Inc stock price today i.e. October 22, 2025 at 1:29 am IST is closed at $34.09,which is 6.70% down from its 52 week high and 179.20% up from its 52 week low.

What is Anaptysbio Inc's market capitalisation today?

Anaptysbio Inc market capitalisation is $0.00T as on October 22, 2025 at 1:29 am IST.

How to invest in Anaptysbio Inc Stock (ANAB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Anaptysbio Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Anaptysbio Inc Shares that will get you 0.0440 shares as per Anaptysbio Inc share price of $34.09 per share as on October 22, 2025 at 1:29 am IST.

What is the minimum amount required to buy Anaptysbio Inc Stock (ANAB) from India?

Indian investors can start investing in Anaptysbio Inc (ANAB) shares with as little as ₹87.755 or $1 (as of October 22, 2025 at 5:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹877.55 in Anaptysbio Inc stock (as per the Rupee-Dollar exchange rate as on October 22, 2025 at 5:41 pm IST). Based on Anaptysbio Inc share’s latest price of $34.09 as on October 22, 2025 at 1:29 am IST, you will get 0.2933 shares of Anaptysbio Inc. Learn more about fractional shares .

What are the returns that Anaptysbio Inc has given to Indian investors in the last 5 years?

Anaptysbio Inc stock has given 31.6% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?